mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.2 |
mRNA |
GDC-0941 |
FIMM |
pan-cancer |
AAC |
0.22 |
0.2 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
-0.06 |
0.2 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.2 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.069 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |